| JNTL Consumer Health II (Switzerland) GmbH - Livostin Nasenspray, Suspension | | 50497 | | 01 | | Livostin Nasenspray | | Suspension | | R01AC02 | | Levocabastin | | 27.06.1994 | | |
| | Composition | | levocabastinum 0.5 mg ut levocabastini hydrochloridum corresp. levocabastinum 0.05 mg pro dosi, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, hypromellosum, polysorbatum 80, dinatrii edetas, propylenglycolum, benzalkonii chloridum 0.15 mg, aqua purificata ad suspensionem pro 1 ml, doses pro vase 86. | | Packungsbestandteile | | Suspension | | | | | | Principe actif | Concentr. |
|---|
| Levocabastine | 0.5 mg/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Benzalkonium Chlorure | 0.15 mg/ml | | Dinatrii Edetas | | | Disodium Phosphate | | | Hypromellosum | | | Sodium Dihydrogenophosphate Monohydrate | | | Polysorbatum 80 | | | Propylenglycol | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 011 | 10 ml | 8.46 | 15.60 | D | | Oui |
|
|
